Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Aisen, K. Davis (1994)
Inflammatory mechanisms in Alzheimer's disease: implications for therapy.The American journal of psychiatry, 151 8
G. Pasinetti (1996)
Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: The role of the complement systemNeurobiology of Aging, 17
G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price, E. Stadlan (1984)
Clinical diagnosis of Alzheimer's diseaseNeurology, 34
R. Kyle (1975)
Multiple myeloma: review of 869 cases.Mayo Clinic proceedings, 50 1
T. Polvikoski, R. Sulkava, M. Haltia, K. Kainulainen, A. Vuorio, A. Verkkoniemi, L. Niinistö, P. Halonen, K. Kontula (1995)
Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.The New England journal of medicine, 333 19
P. Mcgeer, J. Rogers (1992)
Anti‐inflammatory agents as a therapeutic approach to Alzheimer's diseaseNeurology, 42
Haynes RC Jr (1990)
The Pharmacological Basis of Therapeutics
Price DL Sisodia SS (1995)
Role of the βamyloid protein in Alzheimer's diseaseFASEB J, 9
C. Soto, M. Brañes, J. Alvarez, N. Inestrosa (1994)
Structural Determinants of the Alzheimer's Amyloid β‐PeptideJournal of Neurochemistry, 63
J. Rogers, L. Kirby, S. Hempelman, D. Berry, P. Mcgeer, A. Kaszniak, J. Zalinski, M. Cofield, L. Mansukhani, P. Willson, F. Kogan (1993)
Clinical trial of indomethacin in Alzheimer's diseaseNeurology, 43
R. Kyle, M. Gertz (1995)
Primary systemic amyloidosis: clinical and laboratory features in 474 cases.Seminars in hematology, 32 1
N. Inestrosa, C. Soto (1992)
Molecular biology of the amyloid of Alzheimer's disease. An overview.Biological research, 25 2
L. Altstiel, K. Sperber (1991)
Cytokines in Alzheimer's diseaseProgress in Neuro-Psychopharmacology and Biological Psychiatry, 15
C. Caputo, A. Salama (1989)
The amyloid proteins of Alzheimer's disease as potential targets for drug therapyNeurobiology of Aging, 10
L. Thal, D. Salmon, B. Lasker, D. Bower, M. Klauber (1989)
The Safety and Lack of Efficacy of Vinpocetine in Alzheimer's DiseaseJournal of the American Geriatrics Society, 37
Drachman D McKhann G (1984)
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's DiseaseNeurology, 34
Oliverio Vt (1976)
Pharmacology of the nitrosoureas: an overview.Cancer treatment reports, 60
B. Yankner, L. Dawes, Shannon Fisher, L. Villa-komaroff, M. Oster-Granite, R. Neve (1989)
Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.Science, 245 4916
E. Kokmen, J. Naessens, K. Offord (1987)
A short test of mental status: description and preliminary results.Mayo Clinic proceedings, 62 4
T. Hughes, J. Janssen, G. Morgan, P. Martiat, G. Saglio, J. Pignon, FrancoPier Pignatti, K. Mills, Armand Keating, E. Gluckman, C. Bartram, J. Goldman (1990)
False-positive results with PCR to detect leukaemia-specific transcriptThe Lancet, 335
D. Case, B. Lee, B. Clarkson (1977)
Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.The American journal of medicine, 63 6
S. Duursma, J. Aerts, N. Belmatoug, T. Cox, T. Einhorn, J. Esplin, C. Hollak, C. Incerti, G. Pastores, R. Rademakers, R. Zaizov (1995)
Management of Gaucher disease. Current status and future directions: A roundtable discussion.Seminars in Hematology, 32
McGeer E McGeer PL (1992)
Anti-inflammatory drugs and Alzheimer's diseaseLancet, 335
Abstract Objectives: To describe a patient with Alzheimer disease and multiple myeloma (with Bence Jones proteinuria) with improvement of both conditions following cytotoxic chemotherapy, and to present issues related to the pathogenesis and management of Alzheimer disease. Design: Report of a case. Setting: Progressive dementia and myeloma developed in a 64-year-old man. Cytotoxic chemotherapy for the myeloma resulted in maintained improvement of the dementia. Clinical, neuropsychological, pathological, and laboratory data are presented. Main Outcome and Results: For 2 years, vincristine sulfate, carmustine, melphalan, cyclophosphamide, and prednisone were administered cyclically, and the patient's dementia and λ light chain production improved. Severe dementia recurred before death and cessation of therapy, although light chain production remained decreased. Conclusion: Dementia improvement with cytotoxic (ie, immunosuppressive, anti-inflammatory) therapy may offer insight into the pathogenesis and management of Alzheimer disease. References 1. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease . Neurology . 1984;34:939-945.Crossref 2. Inestrosa NC, Soto C. Molecular biology of the amyloid of Alzheimer's disease: an overview . Biol Res . 1992;25:63-72. 3. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein . N Engl J Med . 1995;333:1242-1247.Crossref 4. Kyle RA. Multiple myeloma: review of 869 cases . Mayo Clin Proc . 1975;50:29-40. 5. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases . Semin Hematol . 1995;32:45-59. 6. Kokmen E, Naessens JM, Offord KP. A short test of mental status: description and preliminary results . Mayo Clin Proc . 1987;62:281-288.Crossref 7. Case DC, Lee BJ, Clarkson BD. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol . Am J Med . 1977;63:897-903.Crossref 8. Soto C, Branes C, Alvarez J, Inestrosa NC. Structural determinants of the Alzheimer's amyloid β-peptide . J Neurochem . 1994;63:1191-1198.Crossref 9. McGeer PL, McGeer E, Rogers J, Sibley J. Anti-inflammatory drugs and Alzheimer's disease . Lancet . 1992;335:1037.Crossref 10. Rogers J, Kirby LC, Hempelman SR, et al. Clinical trial of indomethacin in Alzheimer's disease . Neurology . 1993;43:1609-1611.Crossref 11. Calabresi P, Chabner BA. Antineoplastic agents . In: The Pharmacological Basis of Therapeutics . 8th ed. Elmsford, NY: Pergamon Press Inc; 1990;1209-1263. 12. Haynes RC Jr. Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs: inhibitors of the synthesis and actions of adrenocortical hormones . In: The Pharmacological Basis of Therapeutics . 8th ed. Elmsford, NY: Pergamon Press Inc; 1990:1442-1461. 13. Thal LJ, Salivan JP, Lark B. Safety and lack of efficacy of vinpocetine in Alzheimer's disease . J Am Geriatr Soc . 1989;37:515-520. 14. Oliverio VT. Pharmacology of the nitrosoureas: an overview . Cancer Treat Rep . 1976;60:703-707. 15. Caputo CB, Salama Al. The amyloid proteins of Alzheimer's disease as potential targets for drug therapy . Neurobiol Aging . 1989;10:451-461.Crossref 16. Sisodia SS, Price DL. Role of the βamyloid protein in Alzheimer's disease . FASEB J . 1995;9:366-370. 17. Yankner BA, Dawes LR, Fisher S, et al. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease . Science . 1989;245:417-420.Crossref 18. Aisen PS, Davis KL. Inflammatory mechanisms of Alzheimer's disease: implications for therapy . Am J Psychiatry . 1994;151:8. 19. McGeer PL, Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease . Neurology . 1992;42:447-449.Crossref 20. Altstiel L, Sperber K. Cytokines in Alzheimer's disease . Prog Neuropsychopharmacol Biol Psychiatry . 1991;15:481-495.Crossref 21. Pasinetti GM. Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system . Neurobiol Aging . 1996;17:707-716.Crossref
Archives of Neurology – American Medical Association
Published: Apr 1, 1997
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.